PURPOSE: To increase patient knowledge about apixaban (Eliquis, Bristol-Myers Squibb) using an educational video delivered in an urban inpatient setting. METHODS: This prospective, quasi-experimental study evaluated knowledge gain and retention in patients receiving apixaban after viewing a short educational video. Knowledge was assessed with a questionnaire immediately before, immediately after, and one month following the educational video. RESULTS: After 33 patients watched the video, scores increased by 19.7% from the pre-test to the immediate post-test time point (95% confidence interval [CI], 14.5-24.9; P < 0.001). Patients previously receiving apixaban or another anticoagulant were less likely to improve scores compared with new patients (P < 0.05). Twenty-two of the 33 patients (66.7%) completed the one-month follow-up. No difference in scores from pre-test to one month post-test were noted (6.4%; 95% CI, 1.6-14.5; P = 0.11). CONCLUSION: The apixaban educational video led to improvements in short-term knowledge; however, patients did not retain this knowledge at one month. Future studies should seek ways to improve long-term knowledge retention.
PURPOSE: To increase patient knowledge about apixaban (Eliquis, Bristol-Myers Squibb) using an educational video delivered in an urban inpatient setting. METHODS: This prospective, quasi-experimental study evaluated knowledge gain and retention in patients receiving apixaban after viewing a short educational video. Knowledge was assessed with a questionnaire immediately before, immediately after, and one month following the educational video. RESULTS: After 33 patients watched the video, scores increased by 19.7% from the pre-test to the immediate post-test time point (95% confidence interval [CI], 14.5-24.9; P < 0.001). Patients previously receiving apixaban or another anticoagulant were less likely to improve scores compared with new patients (P < 0.05). Twenty-two of the 33 patients (66.7%) completed the one-month follow-up. No difference in scores from pre-test to one month post-test were noted (6.4%; 95% CI, 1.6-14.5; P = 0.11). CONCLUSION: The apixaban educational video led to improvements in short-term knowledge; however, patients did not retain this knowledge at one month. Future studies should seek ways to improve long-term knowledge retention.
Authors: Christine K Superior; Joyce E Broyles; Carrie S Oliphant; Galen D Mack; Denise Thornton Journal: Am J Health Syst Pharm Date: 2002-05-01 Impact factor: 2.637
Authors: Sarah J Moore; Elizabeth A Blair; David R Steeb; Brent N Reed; J Heyward Hull; Jo Ellen Rodgers Journal: Ann Pharmacother Date: 2015-03-18 Impact factor: 3.154
Authors: Bernard L Marini; Kylee Funk; Michael D Kraft; Jessica M Fong; Roxanne Naanos; Stephen M Stout; Deborah Wagner Journal: Patient Educ Couns Date: 2014-05-22
Authors: Tien M Truong; Elizabeth Lipschultz; Keith Danahey; Emily Schierer; Mark J Ratain; Peter H O'Donnell Journal: Clin Transl Sci Date: 2019-09-28 Impact factor: 4.689